Cencora (WBO:ABC) Change In Receivables : €-1,272 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Cencora Change In Receivables?

Cencora's change in receivables for the quarter that ended in Mar. 2025 was €699 Mil. It means Cencora's Accounts Receivable declined by €699 Mil from Dec. 2024 to Mar. 2025 .

Cencora's change in receivables for the fiscal year that ended in Sep. 2024 was €-2,519 Mil. It means Cencora's Accounts Receivable increased by €2,519 Mil from Sep. 2023 to Sep. 2024 .

Cencora's Accounts Receivable for the quarter that ended in Mar. 2025 was €21,936 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cencora's Days Sales Outstanding for the three months ended in Mar. 2025 was 28.68.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cencora's liquidation value for the three months ended in Mar. 2025 was €-37,709 Mil.

Cencora Change In Receivables Historical Data

The historical data trend for Cencora's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Change In Receivables Chart

Cencora Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Change In Receivables

Get a 7-Day Free Trial

-1,792.71

-564.00

-1,626.32

-2,445.18

-2,518.70

Cencora Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-1,083.81	-1,273.61	232.13	-930.41	699.50

Cencora Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,272 Mil.

Cencora (WBO:ABC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cencora's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	21936.382	/	69794.648	*	91
=	28.68

2. In Ben Graham's calculation of liquidation value, Cencora's accounts receivable are only considered to be worth 75% of book value:

Cencora's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1829.706	-	64763.019	+	0.75 * 21936.382	+	0.5 * 17543.089
=	-37,709

Cencora Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cencora's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cencora Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (WBO:ABC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

COR:USA COR:Mexico 0HF3:UK ABG:Germany ABG:Germany C1CO34:Brazil

Address

1 West First Avenue, Conshohocken, PA, USA, 19428-1800

Website

https://www.cencora.com

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora Headlines

No Headlines